Concepedia

Rita Nanda

RN

Statistics

Publications

12

Citations

3.6K

H-Index

12

Active since

2013

Affiliations

University of Chicago Medical Center(Current)

University of Chicago

University of California, San Francisco

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Rita Nanda is an author at University of Chicago Medical Center specializing in medicine, oncology, and pharmacology.

Publications per year

2013–2021

12

Publications

12

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +16

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda, Laura Q.M. Chow, Elizabeth Claire Dees et al. · Journal of Clinical Oncology · 2016 · 1.5K citations · Full text

, , +17

Abstract 2986: Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses

Peter Schmid, Cristina Cruz, Fadi S. Braiteh et al. · Cancer Research · 2017 · 112 citations

, , +17

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer

X. Cynthia, Vera J. Suman, Matthew P. Goetz et al. · Breast Cancer Research and Treatment · 2013 · 51 citations · Full text

, , +12

Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study

Brittany A. Borden, Paige Galecki, Rebecca M. Wellmann et al. · Pharmacogenetics and Genomics · 2018 · 34 citations

, , +15

1–5 of 12